Home > > > > > Report Detail

Global Paclitaxel Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Publisher Name :
Date: 11-Feb-2019
No. of pages: 116

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".

Scope of the Report:

In the last several years, global market of Paclitaxel developed rapidly, with an average growth rate of 12.3%. In 2017, global revenue of Paclitaxel is nearly 80 M USD; the actual production is about 2600 Kg.

The classification of Paclitaxel includes Natural Paclitaxel API and Semi-Synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 is about 31.3%, and the proportion is decreasing trend from 2012 to 2017.

The worldwide market for Paclitaxel is expected to grow at a CAGR of roughly 9.0% over the next five years, will reach 140 million US$ in 2024, from 90 million US$ in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Paclitaxel in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

- Phyton

- ScinoPharm

- Novasep

- Samyang

- Polymed

- TAPI (Teva)

- Fresenius-kabi

- Huiang biopharma

- Southpharma

- Yunnan Hande

- Hainan Yew Pharm

- Jiangsu Yew Biotechnology

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Natural Paclitaxel API

- Semi-synthetic Paclitaxel API

Market Segment by Applications, can be divided into

- Ovarian Cancer

- Cervical Cancer

- Breast Cancer

- Other

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Paclitaxel product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Paclitaxel, with price, sales, revenue and global market share of Paclitaxel in 2017 and 2018.

Chapter 3, the Paclitaxel competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Paclitaxel breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Paclitaxel market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Paclitaxel sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Paclitaxel Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview
1.1 Paclitaxel Introduction
1.2 Market Analysis by Type
1.2.1 Natural Paclitaxel API
1.2.2 Semi-synthetic Paclitaxel API
1.3 Market Analysis by Applications
1.3.1 Ovarian Cancer
1.3.2 Cervical Cancer
1.3.3 Breast Cancer
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Phyton
2.1.1 Business Overview
2.1.2 Paclitaxel Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Phyton Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 ScinoPharm
2.2.1 Business Overview
2.2.2 Paclitaxel Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 ScinoPharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novasep
2.3.1 Business Overview
2.3.2 Paclitaxel Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novasep Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Samyang
2.4.1 Business Overview
2.4.2 Paclitaxel Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Samyang Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Polymed
2.5.1 Business Overview
2.5.2 Paclitaxel Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Polymed Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 TAPI (Teva)
2.6.1 Business Overview
2.6.2 Paclitaxel Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 TAPI (Teva) Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Fresenius-kabi
2.7.1 Business Overview
2.7.2 Paclitaxel Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Fresenius-kabi Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Huiang biopharma
2.8.1 Business Overview
2.8.2 Paclitaxel Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Huiang biopharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Southpharma
2.9.1 Business Overview
2.9.2 Paclitaxel Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Southpharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Yunnan Hande
2.10.1 Business Overview
2.10.2 Paclitaxel Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Yunnan Hande Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Hainan Yew Pharm
2.11.1 Business Overview
2.11.2 Paclitaxel Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Hainan Yew Pharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Jiangsu Yew Biotechnology
2.12.1 Business Overview
2.12.2 Paclitaxel Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Paclitaxel Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Paclitaxel Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Paclitaxel Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Paclitaxel Manufacturer Market Share in 2018
3.3.2 Top 6 Paclitaxel Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Paclitaxel Market Analysis by Regions
4.1 Global Paclitaxel Sales, Revenue and Market Share by Regions
4.1.1 Global Paclitaxel Sales and Market Share by Regions (2014-2019)
4.1.2 Global Paclitaxel Revenue and Market Share by Regions (2014-2019)
4.2 North America Paclitaxel Sales and Growth Rate (2014-2019)
4.3 Europe Paclitaxel Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Paclitaxel Sales and Growth Rate (2014-2019)
4.5 South America Paclitaxel Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Paclitaxel Sales and Growth Rate (2014-2019)
5 North America Paclitaxel by Country
5.1 North America Paclitaxel Sales, Revenue and Market Share by Country
5.1.1 North America Paclitaxel Sales and Market Share by Country (2014-2019)
5.1.2 North America Paclitaxel Revenue and Market Share by Country (2014-2019)
5.2 United States Paclitaxel Sales and Growth Rate (2014-2019)
5.3 Canada Paclitaxel Sales and Growth Rate (2014-2019)
5.4 Mexico Paclitaxel Sales and Growth Rate (2014-2019)
6 Europe Paclitaxel by Country
6.1 Europe Paclitaxel Sales, Revenue and Market Share by Country
6.1.1 Europe Paclitaxel Sales and Market Share by Country (2014-2019)
6.1.2 Europe Paclitaxel Revenue and Market Share by Country (2014-2019)
6.2 Germany Paclitaxel Sales and Growth Rate (2014-2019)
6.3 UK Paclitaxel Sales and Growth Rate (2014-2019)
6.4 France Paclitaxel Sales and Growth Rate (2014-2019)
6.5 Russia Paclitaxel Sales and Growth Rate (2014-2019)
6.6 Italy Paclitaxel Sales and Growth Rate (2014-2019)
7 Asia-Pacific Paclitaxel by Country
7.1 Asia-Pacific Paclitaxel Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Paclitaxel Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Paclitaxel Revenue and Market Share by Country (2014-2019)
7.2 China Paclitaxel Sales and Growth Rate (2014-2019)
7.3 Japan Paclitaxel Sales and Growth Rate (2014-2019)
7.4 Korea Paclitaxel Sales and Growth Rate (2014-2019)
7.5 India Paclitaxel Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Paclitaxel Sales and Growth Rate (2014-2019)
8 South America Paclitaxel by Country
8.1 South America Paclitaxel Sales, Revenue and Market Share by Country
8.1.1 South America Paclitaxel Sales and Market Share by Country (2014-2019)
8.1.2 South America Paclitaxel Revenue and Market Share by Country (2014-2019)
8.2 Brazil Paclitaxel Sales and Growth Rate (2014-2019)
8.3 Argentina Paclitaxel Sales and Growth Rate (2014-2019)
8.4 Colombia Paclitaxel Sales and Growth Rate (2014-2019)
9 Middle East and Africa Paclitaxel by Countries
9.1 Middle East and Africa Paclitaxel Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Paclitaxel Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Paclitaxel Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Paclitaxel Sales and Growth Rate (2014-2019)
9.3 Turkey Paclitaxel Sales and Growth Rate (2014-2019)
9.4 Egypt Paclitaxel Sales and Growth Rate (2014-2019)
9.5 Nigeria Paclitaxel Sales and Growth Rate (2014-2019)
9.6 South Africa Paclitaxel Sales and Growth Rate (2014-2019)
10 Global Paclitaxel Market Segment by Type
10.1 Global Paclitaxel Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Paclitaxel Sales and Market Share by Type (2014-2019)
10.1.2 Global Paclitaxel Revenue and Market Share by Type (2014-2019)
10.2 Natural Paclitaxel API Sales Growth and Price
10.2.1 Global Natural Paclitaxel API Sales Growth (2014-2019)
10.2.2 Global Natural Paclitaxel API Price (2014-2019)
10.3 Semi-synthetic Paclitaxel API Sales Growth and Price
10.3.1 Global Semi-synthetic Paclitaxel API Sales Growth (2014-2019)
10.3.2 Global Semi-synthetic Paclitaxel API Price (2014-2019)
11 Global Paclitaxel Market Segment by Application
11.1 Global Paclitaxel Sales Market Share by Application (2014-2019)
11.2 Ovarian Cancer Sales Growth (2014-2019)
11.3 Cervical Cancer Sales Growth (2014-2019)
11.4 Breast Cancer Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Paclitaxel Market Forecast (2019-2024)
12.1 Global Paclitaxel Sales, Revenue and Growth Rate (2019-2024)
12.2 Paclitaxel Market Forecast by Regions (2019-2024)
12.2.1 North America Paclitaxel Market Forecast (2019-2024)
12.2.2 Europe Paclitaxel Market Forecast (2019-2024)
12.2.3 Asia-Pacific Paclitaxel Market Forecast (2019-2024)
12.2.4 South America Paclitaxel Market Forecast (2019-2024)
12.2.5 Middle East and Africa Paclitaxel Market Forecast (2019-2024)
12.3 Paclitaxel Market Forecast by Type (2019-2024)
12.3.1 Global Paclitaxel Sales Forecast by Type (2019-2024)
12.3.2 Global Paclitaxel Market Share Forecast by Type (2019-2024)
12.4 Paclitaxel Market Forecast by Application (2019-2024)
12.4.1 Global Paclitaxel Sales Forecast by Application (2019-2024)
12.4.2 Global Paclitaxel Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Paclitaxel Picture
Table Product Specifications of Paclitaxel
Figure Global Sales Market Share of Paclitaxel by Types in 2018
Table Paclitaxel Types for Major Manufacturers
Figure Natural Paclitaxel API Picture
Figure Semi-synthetic Paclitaxel API Picture
Figure Paclitaxel Sales Market Share by Applications in 2018
Figure Ovarian Cancer Picture
Figure Cervical Cancer Picture
Figure Breast Cancer Picture
Figure Other Picture
Figure United States Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure France Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure UK Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure China Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure India Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Paclitaxel Revenue (Value) and Growth Rate (2014-2024)
Table Phyton Basic Information, Manufacturing Base and Competitors
Table Phyton Paclitaxel Type and Applications
Table Phyton Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table ScinoPharm Basic Information, Manufacturing Base and Competitors
Table ScinoPharm Paclitaxel Type and Applications
Table ScinoPharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novasep Basic Information, Manufacturing Base and Competitors
Table Novasep Paclitaxel Type and Applications
Table Novasep Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Samyang Basic Information, Manufacturing Base and Competitors
Table Samyang Paclitaxel Type and Applications
Table Samyang Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Polymed Basic Information, Manufacturing Base and Competitors
Table Polymed Paclitaxel Type and Applications
Table Polymed Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table TAPI (Teva) Basic Information, Manufacturing Base and Competitors
Table TAPI (Teva) Paclitaxel Type and Applications
Table TAPI (Teva) Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Fresenius-kabi Basic Information, Manufacturing Base and Competitors
Table Fresenius-kabi Paclitaxel Type and Applications
Table Fresenius-kabi Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Huiang biopharma Basic Information, Manufacturing Base and Competitors
Table Huiang biopharma Paclitaxel Type and Applications
Table Huiang biopharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Southpharma Basic Information, Manufacturing Base and Competitors
Table Southpharma Paclitaxel Type and Applications
Table Southpharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Yunnan Hande Basic Information, Manufacturing Base and Competitors
Table Yunnan Hande Paclitaxel Type and Applications
Table Yunnan Hande Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Hainan Yew Pharm Basic Information, Manufacturing Base and Competitors
Table Hainan Yew Pharm Paclitaxel Type and Applications
Table Hainan Yew Pharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Jiangsu Yew Biotechnology Basic Information, Manufacturing Base and Competitors
Table Jiangsu Yew Biotechnology Paclitaxel Type and Applications
Table Jiangsu Yew Biotechnology Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Paclitaxel Sales by Manufacturer (2017-2018)
Figure Global Paclitaxel Sales Market Share by Manufacturer in 2017
Figure Global Paclitaxel Sales Market Share by Manufacturer in 2018
Table Global Paclitaxel Revenue by Manufacturer (2017-2018)
Figure Global Paclitaxel Revenue Market Share by Manufacturer in 2017
Figure Global Paclitaxel Revenue Market Share by Manufacturer in 2018
Figure Top 3 Paclitaxel Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Paclitaxel Manufacturer (Revenue) Market Share in 2018
Figure Global Paclitaxel Sales and Growth Rate (2014-2019)
Figure Global Paclitaxel Revenue and Growth Rate (2014-2019)
Table Global Paclitaxel Sales by Regions (2014-2019)
Table Global Paclitaxel Sales Market Share by Regions (2014-2019)
Table Global Paclitaxel Revenue by Regions (2014-2019)
Figure Global Paclitaxel Revenue Market Share by Regions in 2014
Figure Global Paclitaxel Revenue Market Share by Regions in 2018
Figure North America Paclitaxel Sales and Growth Rate (2014-2019)
Figure Europe Paclitaxel Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Paclitaxel Sales and Growth Rate (2014-2019)
Figure South America Paclitaxel Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Paclitaxel Sales and Growth Rate (2014-2019)
Figure North America Paclitaxel Revenue and Growth Rate (2014-2019)
Table North America Paclitaxel Sales by Countries (2014-2019)
Table North America Paclitaxel Sales Market Share by Countries (2014-2019)
Figure North America Paclitaxel Sales Market Share by Countries in 2014
Figure North America Paclitaxel Sales Market Share by Countries in 2018
Table North America Paclitaxel Revenue by Countries (2014-2019)
Table North America Paclitaxel Revenue Market Share by Countries (2014-2019)
Figure North America Paclitaxel Revenue Market Share by Countries in 2014
Figure North America Paclitaxel Revenue Market Share by Countries in 2018
Figure United States Paclitaxel Sales and Growth Rate (2014-2019)
Figure Canada Paclitaxel Sales and Growth Rate (2014-2019)
Figure Mexico Paclitaxel Sales and Growth Rate (2014-2019)
Figure Europe Paclitaxel Revenue and Growth Rate (2014-2019)
Table Europe Paclitaxel Sales by Countries (2014-2019)
Table Europe Paclitaxel Sales Market Share by Countries (2014-2019)
Table Europe Paclitaxel Revenue by Countries (2014-2019)
Figure Europe Paclitaxel Revenue Market Share by Countries in 2017
Figure Europe Paclitaxel Revenue Market Share by Countries in 2018
Figure Germany Paclitaxel Sales and Growth Rate (2014-2019)
Figure UK Paclitaxel Sales and Growth Rate (2014-2019)
Figure France Paclitaxel Sales and Growth Rate (2014-2019)
Figure Russia Paclitaxel Sales and Growth Rate (2014-2019)
Figure Italy Paclitaxel Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Paclitaxel Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Paclitaxel Sales by Countries (2014-2019)
Table Asia-Pacific Paclitaxel Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Paclitaxel Sales Market Share by Countries 2018
Table Asia-Pacific Paclitaxel Revenue by Countries (2014-2019)
Figure Asia-Pacific Paclitaxel Revenue Market Share by Countries 2018
Figure China Paclitaxel Sales and Growth Rate (2014-2019)
Figure Japan Paclitaxel Sales and Growth Rate (2014-2019)
Figure Korea Paclitaxel Sales and Growth Rate (2014-2019)
Figure India Paclitaxel Sales and Growth Rate (2014-2019)
Figure Southeast Asia Paclitaxel Sales and Growth Rate (2014-2019)
Figure South America Paclitaxel Revenue and Growth Rate (2014-2019)
Table South America Paclitaxel Sales by Countries (2014-2019)
Table South America Paclitaxel Sales Market Share by Countries (2014-2019)
Figure South America Paclitaxel Sales Market Share by Countries in 2018
Table South America Paclitaxel Revenue by Countries (2014-2019)
Table South America Paclitaxel Revenue Market Share by Countries (2014-2019)
Figure South America Paclitaxel Revenue Market Share by Countries in 2018
Figure Brazil Paclitaxel Sales and Growth Rate (2014-2019)
Figure Argentina Paclitaxel Sales and Growth Rate (2014-2019)
Figure Colombia Paclitaxel Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Paclitaxel Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Paclitaxel Sales by Countries (2014-2019)
Table Middle East and Africa Paclitaxel Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Paclitaxel Sales Market Share by Countries in 2018
Table Middle East and Africa Paclitaxel Revenue by Countries (2014-2019)
Table Middle East and Africa Paclitaxel Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Paclitaxel Revenue Market Share by Countries in 2014
Figure Middle East and Africa Paclitaxel Revenue Market Share by Countries in 2018
Figure Saudi Arabia Paclitaxel Sales and Growth Rate (2014-2019)
Figure UAE Paclitaxel Sales and Growth Rate (2014-2019)
Figure Egypt Paclitaxel Sales and Growth Rate (2014-2019)
Figure Nigeria Paclitaxel Sales and Growth Rate (2014-2019)
Figure South Africa Paclitaxel Sales and Growth Rate (2014-2019)
Table Global Paclitaxel Sales by Type (2014-2019)
Table Global Paclitaxel Sales Share by Type (2014-2019)
Table Global Paclitaxel Revenue by Type (2014-2019)
Table Global Paclitaxel Revenue Share by Type (2014-2019)
Figure Global Natural Paclitaxel API Sales Growth (2014-2019)
Figure Global Natural Paclitaxel API Price (2014-2019)
Figure Global Semi-synthetic Paclitaxel API Sales Growth (2014-2019)
Figure Global Semi-synthetic Paclitaxel API Price (2014-2019)
Table Global Paclitaxel Sales by Application (2014-2019)
Table Global Paclitaxel Sales Share by Application (2014-2019)
Figure Global Cervical Cancer Sales Growth (2014-2019)
Figure Global Breast Cancer Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Paclitaxel Sales, Revenue and Growth Rate (2019-2024)
Table Global Paclitaxel Sales Forecast by Regions (2019-2024)
Table Global Paclitaxel Market Share Forecast by Regions (2019-2024)
Figure North America Sales Paclitaxel Market Forecast (2019-2024)
Figure Europe Sales Paclitaxel Market Forecast (2019-2024)
Figure Asia-Pacific Sales Paclitaxel Market Forecast (2019-2024)
Figure South America Sales Paclitaxel Market Forecast (2019-2024)
Figure Middle East and Africa Sales Paclitaxel Market Forecast (2019-2024)
Table Global Paclitaxel Sales Forecast by Type (2019-2024)
Table Global Paclitaxel Market Share Forecast by Type (2019-2024)
Table Global Paclitaxel Sales Forecast by Application (2019-2024)
Table Global Paclitaxel Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs